期刊文献+

E-钙黏素和β-连接素在滑膜肉瘤中的表达及意义 被引量:4

Expression of E-cadherin and β-catenin and their significance in synovial sarcoma
在线阅读 下载PDF
导出
摘要 目的研究上皮钙粘素(E-cadherin,E-cad)和β连接素(β-catenin,β-cat)在滑膜肉瘤组织中的表达特征及预后意义。方法应用免疫组化方法检测E-cad和β-cat在60例滑膜肉瘤组织中的表达情况,分析其与临床病理特征及患者术后生存时间的关系。结果 E-cad和β-cat的阳性表达率分别为28.3%(17/60)和23.3%(14/60);β-cat异常表达率为45%(27/60)。两者的表达均与滑膜肉瘤的病理学分型及组织学分级有关,β-cat的异常表达还与患者肿瘤部位、TNM分期及转移有关(P<0.05)。E-cad和β-cat表达组的生存情况明显优于β-cat异常表达组(P<0.05)。结论细胞黏附因子E-cad表达下调及β-cat的异常表达提示肿瘤细胞间的黏附力减弱、运动能力加强,肿瘤复发转移潜能增强,患者预后不良。 Objective To investigate the expression of E-cadherin (E-cad) and β-catenin (β-cat) in synovial sarcoma and their prognostic significance. Methods Expression of E-cad and β-cat in 60 cases of synovial sarcoma was detected by immunohistochemistry, and their relevance to tumor clinicopathological data and survival time after operation of patients were analyzed. Results The positive expression rates of biologic markers were as follows: E-cad, 28.3% ( 17/60),β- cat, 23.3% (14/60) ; the abnormal expression rate of β-cat 45% (27/60). Both of them were related to histological typing and tumor grade, the abnormal expression rate of β-cat was correlated with tumor location, clinical stage (TNM) and metastasis (P 〈 0. 05 for all). The survival of synovial sarcoma patients with E-cad and β-cat exproession was significantly better than that with abnormal expression rate of β-cat ( P 〈 0, 05 for all). Conclusion The adhesion among cells is reduced and the motility of tumor cells is increased by the decreased expression of E-cad and the abnormal expression of β-cat, indicating a high potential of recurrence or metastasis and poor prognosis.
出处 《诊断病理学杂志》 CSCD 北大核心 2013年第2期104-107,共4页 Chinese Journal of Diagnostic Pathology
关键词 滑膜肉瘤 上皮钙粘素 Β-连接素 免疫组化 Synovial sarcoma E-cadherin β-catenin Immunohistochemistry
  • 相关文献

参考文献13

  • 1魏永昆,朱虹光,周平,许祖德,王坚,朱雄增.滑膜肉瘤32例临床病理分析[J].诊断病理学杂志,2002,9(2):73-76. 被引量:16
  • 2熊敏,赖日权,安建成,吴惠茜,孔伟贞.免疫组织化学和组织化学在滑膜肉瘤诊断中的意义[J].诊断病理学杂志,1994,1(1):36-37. 被引量:4
  • 3Bergh P, Meis-kindblom JM, Gherlinzoni F, et al. Synovial sarcoma: identifica-tion of low and high risk groups[J]. Cancer, 1999, 85(12): 2596-2607.
  • 4Coindre JM, Trojani M, Contesso G, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma [ J ]. Cancer, 1986, 58(2): 306-309.
  • 5Russell WO, Cohen J, Enzinger F, et al. A clinical and pathological staging system for soft tissue sarcomas [ J]. Cancer, 1977, 40(4) : 1562 - 1570.
  • 6Hasegawa T, Yokoyama R, Matsuno Y, et al. Prognostic significance of histologic grade and nuclear expression of beta- catenin in synovial sarcoma [ J ]. Hum Pathol, 2001, 32 ( 3 ) : 257 - 263.
  • 7Shih HC, Shiozawa T, Miyamoto T, et al. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium:an inverse correlation between E- cadherin and nuclear beta-catenin expression [ J ]. Anticancer Res, 2004, 24(6) : 3843 -3850.
  • 8Fisher C. Synovial sarcoma utrastructuraI and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors [J]. Hum Pathol, 1986, 17 ( 10 ) : 996 - 1008.
  • 9Saito T, Oda Y, Sakamoto A, et al. Prognostic value of the preserved expression of the E-cadherin and catenin families of adhesion molecules and of beta-catenin mutations in synovial sarcoma[J]. J Pathol, 2000, 192(3) : 342 -350.
  • 10Saito T, Oda Y, Sugimachi K, et al. E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features[J]. Am J Pathol, 2001, 159(6): 2117 -2124.

二级参考文献8

  • 1Bergh P,Meis-kindblom JM,Gherlinzoni F,et al.Synovial sarcoma.Identification of low and high risk groups.Cancer,1999,85:2596
  • 2Van de Rijn M,Barr FG,Xiong QB,et al.Poorly differentiated synovial smcoma:an analysis of clinical,pathologic and molecular genetic features.Am J Surg Pathol,1999,23:106
  • 3Meis-Kindblom JM,Stenman n G,Kindblom LG.Differential diagnosis of small round cell rumors.Semin Diagn Pathol,1996,13:213
  • 4Hiraga H,Nojima T,Abe S,et al.Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction:analysis of 84 soft tissue and bone tumors.Diag Mol Pathol,1998,7:102
  • 5Guillou L,Wadden C,Kraus MD,et al.S-100 protein reactivity in synovial sarcoma-a potentially frequent diagnostic pitfall.Applied Immunohistochemistry,1996,4:167
  • 6Suster S,Fisher C,Moran CA.Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue,skin,serosal surfaces and gastrointestinal tract.Am J Surg Pathol,1998,22:863
  • 7Smith TA,Machen SK,Fisher C,et al.Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor.Am J Clin Pathol,1999,112:641
  • 8Folpe AL,Schmidt RA,chapman D,et al.Poorly differentiated synovial sarcoma:immunohistochemical distinction from primitive neuroectodemal tumors and high-grade malignant peripheral nerve sheath tumors.Am J Surg Pathol,1998,22:673

共引文献18

同被引文献39

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部